Triomi Medical
NYC-based Triomi offers a portable 12-lead EKG, integrating with smart devices for on-the-go heart disease diagnosis.
NYC-based Triomi offers a portable 12-lead EKG, integrating with smart devices for on-the-go heart disease diagnosis.
Founded in New York City, Triomi Medical aims to revolutionize heart disease diagnosis with its portable 12-lead EKG device. The company's core mission is to provide healthcare practitioners with a reliable, cost-effective tool for on-the-go heart disease diagnosis. Triomi's EKG device integrates seamlessly with various smart devices, including iPhone, Android, Windows, and Mac platforms, allowing for immediate reading and interpretation of results. The market focus includes private practices, home care settings, ambulances, and hospitals.
Notable affiliated individuals and investors have not been disclosed publicly. However, Triomi Medical has achieved significant milestones by improving patient care through its innovative product. The compact and user-friendly design of the Triomi 12-Lead EKG has made it an essential tool for healthcare providers, enhancing diagnostic accuracy and efficiency. The overall impact of Triomi Medical is evident in its contribution to timely and accurate heart disease diagnosis, ultimately saving lives and reducing healthcare costs.
Companies similar to Triomi Medical include QT Medical, Altrix Medical, Strohl Medical Technologies and AugMI Labs.
Triomi Medical was founded in 2014.
Triomi Medical's headquarters is located in New York City, NY, US.
Triomi Medical's most recent funding round was for $120k (USD) in March 2015.
As of Mar 9, 2015, Triomi Medical has disclosed funding of $120k (USD). Undisclosed round amounts are excluded.
Triomi Medical has 5 employees as of Feb 4, 2024.
AugMI Labs
